BioPharmX Corp fka BPMX

[Whos_Who]

In recent action, BioPharmX Corporation (BPMX) has made a move of +44.23% over the past month, which has come on weak relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 22.62, and it’s gotten there by action that has been less volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 6.78% with $38.06 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of BPMX.

http://stocknewsjournal.com/2017/04/18/the-case-for-and-against-biopharmx-corporation-bpmx-2/